CONTINUING MEDICAL EDUCATION



Program release date: November 30, 2007

About the Activity

This activity is based on review articles in the journal ONCOLOGY. It is developed from an identified educational need for information about practical management issues in the practice of medical, surgical, and radiation oncology. This activity has been developed and approved under the direction of Beam Institute.

Learning Objectives

• Review the current standards of care for treating locally advanced and metastatic pancreatic cancer.
• Consider the benefits of hematopoietic stem cell transplantation performed in elderly patients diagnosed with hematologic malignancies.
• Describe the history, symptoms, and laboratory findings of a patient with renal carcinoid tumor found to have sarcoidosis, and review expert findings on management of the patient.
• Discuss current knowledge of the etiology, symptoms, and surgical and medical treatment of renal carcinoid tumors

If you have not read this month's issue of ONCOLOGY or want to review these articles online, click their titles at the top right of this page.

Target Audience

This activity targets physicians in the fields of oncology and hematology.

Accreditation

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Countinuing Medical Education through the joint sponsorship of Beam Institute and The Oncology Group. Beam Institute is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

The Beam Institute designates this educational activity for a maximum of 3 AMA PRA Category 1 Credits(s)^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

If you achieve an 80% or higher on your online post-test, you will be able to complete the evaluation and print your CME certificate. If you have any difficulty accessing the post-test online, contact Beam Institute (see contact information below) to have the forms sent to you.

Compliance Statement

This activity is an independent educational activity under the direction of Beam Institute. The activity was planned and implemented in accordance with the Essential Areas and policies of the ACCME, the Ethical Opinions/Guidelines of the AMA, the FDA, the OIG, and the PhRMA Code on Interactions With Healthcare Professionals, thus assuring the highest degree of independence, fair balance, scientific rigor, and objectivity.

However, Beam Institute, the Grantor, and CMP Healthcare Media shall in no way be liable for the currency of information or for any errors, omissions, or inaccuracies in the activity. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s), or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Activity participants are encouraged to refer to primary references or full prescribing information resources.

The opinions and recommendations presented herein are those of the author(s) and do not necessarily reflect the views of the provider or producer.

Financial Disclosures

Authors' disclosures of potential conflicts of interest are found on the first page of each article.

Copyright

Copyrights owned by Beam Institute, a division of CME LLC. Copyright 2007, CME LLC. All rights reserved.

Post-Test and Evaluation

CME post-test and evaluation are available online at www.cancernetwork.com/cme.

Contact Information

We would like to hear your comments regarding this or other activities provided by Beam Institute. Suggestions for future activities are also welcome. Contact us at:

Address:
Director of Continuing Education
Beam Institute
11 West 19th Street, 3rd Floor
New York, NY 10011-4280
Phone: 888-618-5781
Fax: 212-600-3050
e-mail: beaminstitute@cmp.com